Literature DB >> 24676677

Evaluation of angiogenesis in non-small cell lung carcinoma by CD34 immunohistochemistry.

Zhu Bing1, Yang Jian-ru, Jiang Yao-quan, Chen Shi-feng.   

Abstract

The objective of the study was to investigate angiogenesis in non-small lung cancer by measuring the expression of CD34. Immunohistochemistry was used to detect CD34 at the endothelial cell surface in 81 surgically resected non-small cell lung cancer specimens. CD34 immunohistochemistry had high specificity and sensitivity with minimal background, which enabled efficient identification of CD34-positive staining. Statistical analysis showed that increased microvessel density (MVD) was closely correlated to tumor progression as reflected by the clinical stage (P < 0.05). However, MVD was not significantly associated with lymph node metastasis and other clinical and pathological features (P > 0.05). In conclusion, microvascular density may play an important role in the development and progression of lung cancer.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24676677     DOI: 10.1007/s12013-014-9916-5

Source DB:  PubMed          Journal:  Cell Biochem Biophys        ISSN: 1085-9195            Impact factor:   2.194


  8 in total

1.  Detailed assessment of microvasculature markers in non-small cell lung cancer reveals potentially clinically relevant characteristics.

Authors:  Geoffrey Pomme; Florian Augustin; Michael Fiegl; Raoul A Droeser; William Sterlacci; Alexandar Tzankov
Journal:  Virchows Arch       Date:  2015-04-09       Impact factor: 4.064

2.  Surface-engineered nanostructured lipid carrier systems for synergistic combination oncotherapy of non-small cell lung cancer.

Authors:  Shruti Rawal; Vivek Bora; Bhoomika Patel; Mayur Patel
Journal:  Drug Deliv Transl Res       Date:  2020-11-19       Impact factor: 4.617

3.  Presence of intra-tumoral CD61+ megakaryocytes predicts poor prognosis in non-small cell lung cancer.

Authors:  Weizhe Huang; Shen Zhao; Wei Xu; Zhikui Zhang; Xiangdong Ding; Jianxing He; Wenhua Liang
Journal:  Transl Lung Cancer Res       Date:  2019-08

4.  Lymphangiogenesis in Classical Hodgkin Lymphoma - Preliminary Study with Clinicopathological Correlations.

Authors:  Daniel Benharroch; Isebrand Prinsloo; Jacob Gopas; Irena Lazarev
Journal:  J Cancer       Date:  2016-10-23       Impact factor: 4.207

5.  Fibroblast Growth Factor Receptor 1 (FGFR1), Partly Related to Vascular Endothelial Growth Factor Receptor 2 (VEGFR2) and Microvessel Density, is an Independent Prognostic Factor for Non-Small Cell Lung Cancer.

Authors:  Dan Pu; Jiewei Liu; Zhixi Li; Jiang Zhu; Mei Hou
Journal:  Med Sci Monit       Date:  2017-01-15

6.  Microvascular proliferation is associated with aggressive tumour features and reduced survival in lung adenocarcinoma.

Authors:  Maria Ramnefjell; Christina Aamelfot; Sura Aziz; Lars Helgeland; Lars A Akslen
Journal:  J Pathol Clin Res       Date:  2017-09-12

7.  CD34 and Bcl-2 as predictors for the efficacy of neoadjuvant chemotherapy in cervical cancer.

Authors:  Yun Lin; Zhi Li; Mubiao Liu; Haiyan Ye; Jianhui He; Jianguo Chen
Journal:  Arch Gynecol Obstet       Date:  2021-01-03       Impact factor: 2.344

8.  Evaluation of Angiogenesis and Pathological Classification of Extrahepatic Cholangiocarcinoma by Dynamic MR Imaging for E-Healthcare.

Authors:  Jinyun Tan; Xijun Sun; Shaoyu Wang; Baoqin Ma; Zhaohui Chen; Yaowei Shi; Li Zhang; Mohd Asif Shah
Journal:  J Healthc Eng       Date:  2021-10-11       Impact factor: 2.682

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.